Vana Papaevangelou

Athens, ESYE31, GR 
Athens, ESYE31, GR 

Overview

Vana Papaevangelou practices practicing medicine in Athens, Greece.

Her clinical expertise encompasses Congenital Cytomegalovirus, Cytomegalic Inclusion Disease, Cytomegalovirus Infection, and Meningitis.

She is actively involved in clinical research, co-authoring 9 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

Athens, ESYE31, Greece
Other Locations
Alexandroupoli, ESYE11, Greece

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

An Open-label, Non-comparator, Multicenter Study to Describe the Pharmacokinetics (PK), Pharmacodynamics (PD; Viral Load) and Safety Following a Single Intravenous or Intramuscular Dose of Sotrovimab in Pediatric Participants With Mild to Moderate COVID-19 at High Risk of Disease Progression
An Open-label, Non-comparator, Multicenter Study to Describe the Pharmacokinetics (PK), Pharmacodynamics (PD; Viral Load) and Safety Following a Single Intravenous or Intramuscular Dose of Sotrovimab in Pediatric Participants With Mild to Moderate COVID-19 at High Risk of Disease Progression
Enrollment Status: Terminated
Publish Date: January 03, 2024
Intervention Type: Biological
Study Drug: Sotrovimab
Study Phase: Phase 2

9 Total Publications

The Viral Hepatitis Prevention Board (VHPB) supports the continued recommendation for universal hepatitis B vaccination of all newborns within 24 hours of birth.
The Viral Hepatitis Prevention Board (VHPB) supports the continued recommendation for universal hepatitis B vaccination of all newborns within 24 hours of birth.
Journal: Human vaccines & immunotherapeutics
Published: December 11, 2025

Frequently Asked Questions about Vana Papaevangelou

Is Vana Papaevangelou a top-rated expert for Congenital Cytomegalovirus?

MediFind is an objective health platform that identifies experts based on real-world data. Vana Papaevangelou is classified as an Experienced expert for Congenital Cytomegalovirus, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Vana Papaevangelou participate in research or clinical trials?

Yes. Vana Papaevangelou has published 9 articles and abstracts on conditions like Congenital Cytomegalovirus. You can view a list of Vana Papaevangelou's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Papaevangelou's expertise for a condition
ConditionClose
        View All 7 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile